US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COYA THERAPEUTICS INC

4.40

-0.1000-2.22%

Post-market: 4.400.00000.00%16:10 EDT

Volume:67.96K

Turnover:302.99K

Market Cap:103.17M

PE:-3.66

High:4.61

Open:4.53

Low:4.37

Close:4.50

52wk High:7.75

52wk Low:3.94

Shares:23.45M

Float Shares:17.82M

Volume Ratio:0.49

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2006

EPS(LYR):-0.9765

ROE:-62.18%

ROA:-37.15%

PB:3.78

PE(LYR):-4.51

Loading ...

Overview Company News Filings

BRIEF-Coya Therapeutics Receives Clinical Trial Application Acceptance From Health Canada

Coya Therapeutics Secures Health Canada Approval to Begin ALS Trial

Coya Therapeutics Inc - Alstars Trial Underway in US and Canada

THOMSON REUTERS

Coya Therapeutics Receives Clinical Trial Application (Cta) Acceptance From Health Canada to Proceed With the Coya 302 Alstars Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

THOMSON REUTERS

Coya Therapeutics Receives $4.2 Million Milestone Payment for ALS Trial Initiation

Coya Therapeutics Begins Dosing ALS Patients in ALSTARS Trial of COYA 302

Coya Therapeutics Announces Patients Have Been Dosed in the Alstars Trial of Coya 302 for the Treatment of ALS

THOMSON REUTERS

Coya Therapeutics to Join Evercore Healthcare and CTAD Conferences

Coya Therapeutics reports $3.6 million collaboration revenue for Q3 2025

Coya Therapeutics Inc: Anticipate Extending Our Runway Into 2H 2027 and Past Alstars Topline Readout

THOMSON REUTERS

Coya Therapeutics Qtrly EPS $-0.13

THOMSON REUTERS

Press Release: Coya Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update

Coya Therapeutics announces results from COYA 303 in vivo animal study

Coya Therapeutics Reports COYA 303 Shows Potent Anti-Inflammatory Effects in Preclinical Study

Coya Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Greenlight Capital's Einhorn Opts Out of AI Frenzy: "The Math Doesn't Add Up"

Coya Therapeutics Shares Fall 4.5% After Co Prices Stock Offering

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Cipher Mining, Kura, GrafTech

BUZZ-Coya Therapeutics plunges after upsized $20 million share sale

Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COYA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","market":"US","secType":"STK","nameCN":"COYA THERAPEUTICS INC","latestPrice":4.4,"timestamp":1773777600000,"preClose":4.5,"halted":0,"volume":67955,"hourTrading":{"tag":"盘后","latestPrice":4.4,"preClose":4.4,"latestTime":"16:10 EDT","volume":568,"amount":2499.2,"timestamp":1773778204134,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.022222222222222143,"floatShares":17824800,"shares":23447199,"eps":-1.2006,"marketStatus":"Not Yet Opened","change":-0.1,"latestTime":"03-17 16:00:00 EDT","open":4.53,"high":4.61,"low":4.37,"amount":302992.9322,"amplitude":0.053333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.2006,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773820800000},"marketStatusCode":0,"adr":0,"listingDate":1672290000000,"exchange":"NASDAQ","adjPreClose":4.5,"postHourTrading":{"tag":"盘后","latestPrice":4.4,"preClose":4.4,"latestTime":"16:10 EDT","volume":568,"amount":2499.2,"timestamp":1773778204134,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.488189,"impliedVol":2.7148,"impliedVolPercentile":0.872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","floatShares":17824800,"roa":"-37.15%","roe":"-62.18%","lyrEps":-0.976498,"volumeRatio":0.488189,"shares":23447199,"dividePrice":0,"high":4.61,"amplitude":0.053333,"preClose":4.5,"low":4.37,"week52Low":3.9401,"pbRate":"3.78","psRate":"25.87","week52High":7.75,"institutionHeld":0,"latestPrice":4.4,"eps":-1.2006,"divideRate":0,"volume":67955,"delay":0,"ttmEps":-1.2006,"open":4.53,"prevYearClose":5.8,"prevWeekClose":4.53,"prevMonthClose":4.96,"prevQuarterClose":5.8,"fiveDayClose":4.9,"twentyDayClose":4.65,"sixtyDayClose":5.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-16","symbol":"COYA","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2025-11-12","symbol":"COYA","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-08-12","symbol":"COYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1752120000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COYA","date":"2026-03-16","current":-3.970488,"percent":0.556533,"low":-18.170827,"twenty":-9.931121,"median":-6.125431,"eighty":-3.905437,"high":-2.532969,"avg":-7.0463,"sd":3.402606,"marketCap":106215738},"quantilePoints":[{"date":"2022-12-30","current":-4.259584,"twenty":-5.088378,"median":-4.673981,"eighty":-4.199135,"marketCap":45862003},{"date":"2023-01-06","current":-4.198451,"twenty":-4.75686,"median":-4.211892,"eighty":-4.164199,"marketCap":45203803},{"date":"2023-01-13","current":-4.315322,"twenty":-4.421315,"median":-4.259584,"eighty":-4.180381,"marketCap":46462126},{"date":"2023-01-20","current":-4.288262,"twenty":-4.396143,"median":-4.253021,"eighty":-4.180381,"marketCap":46170776},{"date":"2023-01-27","current":-4.181765,"twenty":-4.394298,"median":-4.256303,"eighty":-4.180658,"marketCap":45024142},{"date":"2023-02-03","current":-3.675163,"twenty":-4.351211,"median":-4.234322,"eighty":-4.117451,"marketCap":39569675},{"date":"2023-02-10","current":-3.877804,"twenty":-4.30991,"median":-4.190108,"eighty":-3.84096,"marketCap":41751462},{"date":"2023-02-17","current":-3.850171,"twenty":-4.288262,"median":-4.180381,"eighty":-3.855698,"marketCap":41453946},{"date":"2023-02-24","current":-3.684374,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":39668848},{"date":"2023-03-03","current":-4.089655,"twenty":-4.270282,"median":-4.071233,"eighty":-3.770128,"marketCap":44032421},{"date":"2023-03-10","current":-4.23703,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":45619175},{"date":"2023-03-17","current":-3.905437,"twenty":-4.29377,"median":-4.180381,"eighty":-3.822538,"marketCap":42048978},{"date":"2023-03-24","current":-3.73964,"twenty":-4.288262,"median":-4.108461,"eighty":-3.73964,"marketCap":40263880},{"date":"2023-03-31","current":-3.218192,"twenty":-4.288262,"median":-4.048207,"eighty":-3.707402,"marketCap":39406041},{"date":"2023-04-06","current":-3.099387,"twenty":-4.273878,"median":-3.979124,"eighty":-3.684448,"marketCap":37951295},{"date":"2023-04-14","current":-3.233436,"twenty":-4.261724,"median":-3.905437,"eighty":-3.63832,"marketCap":39592701},{"date":"2023-04-21","current":-3.534032,"twenty":-4.256278,"median":-3.877804,"eighty":-3.512909,"marketCap":43273430},{"date":"2023-04-28","current":-3.753386,"twenty":-4.253993,"median":-3.850523,"eighty":-3.541339,"marketCap":45959367},{"date":"2023-05-05","current":-4.053981,"twenty":-4.248953,"median":-3.850876,"eighty":-3.590423,"marketCap":49640095},{"date":"2023-05-12","current":-3.858435,"twenty":-4.25448,"median":-3.877804,"eighty":-3.627267,"marketCap":51231762},{"date":"2023-05-19","current":-4.210564,"twenty":-4.257931,"median":-3.905437,"eighty":-3.63832,"marketCap":55907282},{"date":"2023-05-26","current":-3.109224,"twenty":-4.25448,"median":-3.877804,"eighty":-3.560217,"marketCap":41283847},{"date":"2023-06-02","current":-3.431385,"twenty":-4.251665,"median":-3.850876,"eighty":-3.429011,"marketCap":45561450},{"date":"2023-06-09","current":-3.611196,"twenty":-4.244399,"median":-3.84096,"eighty":-3.421013,"marketCap":47948950},{"date":"2023-06-16","current":-3.618688,"twenty":-4.23703,"median":-3.850171,"eighty":-3.424798,"marketCap":48048429},{"date":"2023-06-23","current":-3.566243,"twenty":-4.23703,"median":-3.830566,"eighty":-3.428417,"marketCap":47352075},{"date":"2023-06-30","current":-3.146685,"twenty":-4.23703,"median":-3.818461,"eighty":-3.418016,"marketCap":41781243},{"date":"2023-07-07","current":-3.071764,"twenty":-4.235405,"median":-3.785695,"eighty":-3.362458,"marketCap":40786451},{"date":"2023-07-14","current":-3.041795,"twenty":-4.228928,"median":-3.76675,"eighty":-3.288681,"marketCap":40388534},{"date":"2023-07-21","current":-2.981859,"twenty":-4.224887,"median":-3.746054,"eighty":-3.233436,"marketCap":39592701},{"date":"2023-07-28","current":-3.019319,"twenty":-4.216174,"median":-3.721218,"eighty":-3.218192,"marketCap":40090097},{"date":"2023-08-04","current":-2.876969,"twenty":-4.203296,"median":-3.712007,"eighty":-3.16841,"marketCap":38199993},{"date":"2023-08-11","current":-2.839996,"twenty":-4.188439,"median":-3.693585,"eighty":-3.145639,"marketCap":36807285},{"date":"2023-08-18","current":-2.54832,"twenty":-4.180935,"median":-3.684466,"eighty":-3.105289,"marketCap":33027077},{"date":"2023-08-25","current":-2.709509,"twenty":-4.180381,"median":-3.675163,"eighty":-3.078507,"marketCap":35116139},{"date":"2023-09-01","current":-2.709509,"twenty":-4.180381,"median":-3.63832,"eighty":-3.046291,"marketCap":35116139},{"date":"2023-09-08","current":-3.691995,"twenty":-4.169593,"median":-3.63832,"eighty":-3.044792,"marketCap":47849471},{"date":"2023-09-15","current":-3.546157,"twenty":-4.135431,"median":-3.63832,"eighty":-3.058278,"marketCap":45959367},{"date":"2023-09-21","current":-3.031887,"twenty":-4.1047,"median":-3.619293,"eighty":-3.053783,"marketCap":39294264},{"date":"2023-09-29","current":-3.162374,"twenty":-4.08252,"median":-3.599887,"eighty":-3.071764,"marketCap":40985409},{"date":"2023-10-06","current":-2.594374,"twenty":-4.053747,"median":-3.556227,"eighty":-3.033869,"marketCap":33623952},{"date":"2023-10-13","current":-3.745724,"twenty":-4.05097,"median":-3.54621,"eighty":-3.041795,"marketCap":48545825},{"date":"2023-10-20","current":-3.937616,"twenty":-4.036232,"median":-3.575206,"eighty":-3.043294,"marketCap":51032803},{"date":"2023-10-27","current":-3.645941,"twenty":-4.021495,"median":-3.590557,"eighty":-3.046291,"marketCap":47252596},{"date":"2023-11-03","current":-3.684319,"twenty":-3.985193,"median":-3.599887,"eighty":-3.062774,"marketCap":47749992},{"date":"2023-11-10","current":-3.870934,"twenty":-4.021495,"median":-3.619293,"eighty":-3.071764,"marketCap":47850465},{"date":"2023-11-17","current":-4.057134,"twenty":-4.055242,"median":-3.63832,"eighty":-3.071764,"marketCap":50152180},{"date":"2023-11-24","current":-4.259991,"twenty":-4.064747,"median":-3.645941,"eighty":-3.07577,"marketCap":52659789},{"date":"2023-12-01","current":-4.324905,"twenty":-4.105159,"median":-3.675163,"eighty":-3.082268,"marketCap":53462223},{"date":"2023-12-08","current":-5.631302,"twenty":-4.180381,"median":-3.684374,"eighty":-3.084048,"marketCap":69611225},{"date":"2023-12-15","current":-7.875233,"twenty":-4.205719,"median":-3.689056,"eighty":-3.088687,"marketCap":97349529},{"date":"2023-12-22","current":-7.933482,"twenty":-4.235947,"median":-3.693585,"eighty":-3.093672,"marketCap":98069570},{"date":"2023-12-29","current":-8.842163,"twenty":-4.23703,"median":-3.709704,"eighty":-3.09424,"marketCap":109302208},{"date":"2024-01-05","current":-7.793685,"twenty":-4.253993,"median":-3.715021,"eighty":-3.09424,"marketCap":96341472},{"date":"2024-01-12","current":-7.877698,"twenty":-4.259991,"median":-3.721218,"eighty":-3.097328,"marketCap":97379997},{"date":"2024-01-19","current":-6.724011,"twenty":-4.272114,"median":-3.742682,"eighty":-3.100019,"marketCap":83118725},{"date":"2024-01-26","current":-6.99204,"twenty":-4.300291,"median":-3.753386,"eighty":-3.10427,"marketCap":86431950},{"date":"2024-02-02","current":-7.213454,"twenty":-4.321125,"median":-3.76675,"eighty":-3.109224,"marketCap":89168961},{"date":"2024-02-09","current":-7.935965,"twenty":-4.359055,"median":-3.785695,"eighty":-3.121212,"marketCap":98100263},{"date":"2024-02-16","current":-8.91485,"twenty":-4.404211,"median":-3.812795,"eighty":-3.139255,"marketCap":110200736},{"date":"2024-02-23","current":-10.04523,"twenty":-4.438913,"median":-3.822509,"eighty":-3.140292,"marketCap":124173901},{"date":"2024-03-01","current":-10.476406,"twenty":-5.628056,"median":-3.830566,"eighty":-3.144593,"marketCap":129503871},{"date":"2024-03-08","current":-10.441446,"twenty":-5.900696,"median":-3.837832,"eighty":-3.146685,"marketCap":129071712},{"date":"2024-03-15","current":-11.653399,"twenty":-6.72168,"median":-3.850171,"eighty":-3.146685,"marketCap":144053250},{"date":"2024-03-22","current":-18.042053,"twenty":-6.870845,"median":-3.854655,"eighty":-3.146752,"marketCap":144116957},{"date":"2024-03-28","current":-17.568699,"twenty":-6.99204,"median":-3.858435,"eighty":-3.147022,"marketCap":140335887},{"date":"2024-04-05","current":-16.744948,"twenty":-7.213454,"median":-3.877804,"eighty":-3.154698,"marketCap":133755895},{"date":"2024-04-12","current":-16.708387,"twenty":-7.481482,"median":-3.895399,"eighty":-3.162374,"marketCap":133463852},{"date":"2024-04-19","current":-15.428751,"twenty":-7.933482,"median":-3.905437,"eighty":-3.168361,"marketCap":123242331},{"date":"2024-04-26","current":-15.41047,"twenty":-7.947618,"median":-3.91531,"eighty":-3.168442,"marketCap":123096309},{"date":"2024-05-03","current":-16.050288,"twenty":-8.108228,"median":-3.925864,"eighty":-3.184145,"marketCap":128207070},{"date":"2024-05-10","current":-15.465312,"twenty":-8.157379,"median":-3.945867,"eighty":-3.193076,"marketCap":123534375},{"date":"2024-05-17","current":-12.046492,"twenty":-8.434421,"median":-4.006757,"eighty":-3.19913,"marketCap":124118462},{"date":"2024-05-24","current":-12.027546,"twenty":-8.842163,"median":-4.037702,"eighty":-3.208428,"marketCap":123923260},{"date":"2024-05-31","current":-11.25722,"twenty":-9.523158,"median":-4.053396,"eighty":-3.216239,"marketCap":115986366},{"date":"2024-06-07","current":-10.62197,"twenty":-10.30363,"median":-4.063993,"eighty":-3.218192,"marketCap":109441204},{"date":"2024-06-14","current":-10.636743,"twenty":-10.491151,"median":-4.092919,"eighty":-3.222662,"marketCap":109593417},{"date":"2024-06-21","current":-8.937819,"twenty":-10.481448,"median":-4.104334,"eighty":-3.228445,"marketCap":92088913},{"date":"2024-06-28","current":-8.952592,"twenty":-10.45543,"median":-4.153411,"eighty":-3.232684,"marketCap":92241126},{"date":"2024-07-05","current":-9.602615,"twenty":-10.38956,"median":-4.180381,"eighty":-3.233436,"marketCap":98938502},{"date":"2024-07-12","current":-11.065167,"twenty":-10.462422,"median":-4.190108,"eighty":-3.233436,"marketCap":114007596},{"date":"2024-07-19","current":-10.341278,"twenty":-10.495432,"median":-4.22459,"eighty":-3.240692,"marketCap":106549156},{"date":"2024-07-26","current":-10.858342,"twenty":-10.601287,"median":-4.235676,"eighty":-3.260565,"marketCap":111876613},{"date":"2024-08-02","current":-9.30715,"twenty":-10.601287,"median":-4.23703,"eighty":-3.276491,"marketCap":95894240},{"date":"2024-08-09","current":-8.952592,"twenty":-10.592423,"median":-4.254237,"eighty":-3.285234,"marketCap":92241126},{"date":"2024-08-16","current":-7.71646,"twenty":-10.555339,"median":-4.259991,"eighty":-3.293463,"marketCap":77933096},{"date":"2024-08-23","current":-9.253723,"twenty":-10.495432,"median":-4.262601,"eighty":-3.309966,"marketCap":93458831},{"date":"2024-08-30","current":-9.08794,"twenty":-10.483969,"median":-4.273335,"eighty":-3.333614,"marketCap":91784487},{"date":"2024-09-06","current":-9.057798,"twenty":-10.475972,"median":-4.288262,"eighty":-3.336985,"marketCap":91480061},{"date":"2024-09-13","current":-9.645575,"twenty":-10.467679,"median":-4.305376,"eighty":-3.353467,"marketCap":97416371},{"date":"2024-09-20","current":-9.20851,"twenty":-10.421412,"median":-4.315454,"eighty":-3.374246,"marketCap":93002191},{"date":"2024-09-27","current":-10.188138,"twenty":-10.338323,"median":-4.344348,"eighty":-3.38688,"marketCap":102896042},{"date":"2024-10-04","current":-10.941699,"twenty":-10.338323,"median":-4.360183,"eighty":-3.395897,"marketCap":110506696},{"date":"2024-10-11","current":-10.625204,"twenty":-10.475972,"median":-4.389011,"eighty":-3.411186,"marketCap":107310221},{"date":"2024-10-18","current":-12.056969,"twenty":-10.583908,"median":-4.422276,"eighty":-3.421013,"marketCap":121770464},{"date":"2024-10-25","current":-13.503805,"twenty":-10.624557,"median":-4.764496,"eighty":-3.424798,"marketCap":136382919},{"date":"2024-11-01","current":-10.610132,"twenty":-10.639569,"median":-5.615074,"eighty":-3.429011,"marketCap":107158008},{"date":"2024-11-08","current":-11.259019,"twenty":-10.689241,"median":-5.753016,"eighty":-3.447868,"marketCap":120460649},{"date":"2024-11-15","current":-9.869209,"twenty":-10.838842,"median":-5.907187,"eighty":-3.515296,"marketCap":105591027},{"date":"2024-11-22","current":-10.150294,"twenty":-10.747842,"median":-6.613304,"eighty":-3.52129,"marketCap":108598366},{"date":"2024-11-29","current":-10.181526,"twenty":-10.695836,"median":-6.758971,"eighty":-3.52129,"marketCap":108932515},{"date":"2024-12-06","current":-9.556893,"twenty":-10.66286,"median":-6.852199,"eighty":-3.534032,"marketCap":102249538},{"date":"2024-12-13","current":-9.197728,"twenty":-10.640275,"median":-6.968732,"eighty":-3.546157,"marketCap":98406827},{"date":"2024-12-20","current":-8.182699,"twenty":-10.636743,"median":-6.99204,"eighty":-3.54621,"marketCap":87546990},{"date":"2024-12-27","current":-9.244576,"twenty":-10.634857,"median":-7.16684,"eighty":-3.558448,"marketCap":98908050},{"date":"2025-01-03","current":-9.541277,"twenty":-10.628876,"median":-7.256788,"eighty":-3.564349,"marketCap":102082464},{"date":"2025-01-10","current":-9.010338,"twenty":-10.62391,"median":-7.341641,"eighty":-3.567419,"marketCap":96401934},{"date":"2025-01-17","current":-8.401321,"twenty":-10.617235,"median":-7.51608,"eighty":-3.569184,"marketCap":89886032},{"date":"2025-01-24","current":-9.213344,"twenty":-10.609545,"median":-7.731531,"eighty":-3.571593,"marketCap":98573901},{"date":"2025-01-31","current":-9.494429,"twenty":-10.604242,"median":-7.875233,"eighty":-3.584959,"marketCap":101581241},{"date":"2025-02-07","current":-10.665617,"twenty":-10.609545,"median":-7.934724,"eighty":-3.602149,"marketCap":114111822},{"date":"2025-02-14","current":-10.61877,"twenty":-10.62133,"median":-7.947618,"eighty":-3.612694,"marketCap":113610598},{"date":"2025-02-21","current":-10.009752,"twenty":-10.61877,"median":-7.957599,"eighty":-3.618688,"marketCap":107094696},{"date":"2025-02-28","current":-11.056013,"twenty":-10.61877,"median":-8.042226,"eighty":-3.619898,"marketCap":118288682},{"date":"2025-03-07","current":-10.743696,"twenty":-10.62197,"median":-8.108228,"eighty":-3.622913,"marketCap":114947194},{"date":"2025-03-14","current":-10.134679,"twenty":-10.61877,"median":-8.140788,"eighty":-3.63832,"marketCap":108431292},{"date":"2025-03-21","current":-7.507868,"twenty":-10.61877,"median":-8.131528,"eighty":-3.63832,"marketCap":111722986},{"date":"2025-03-28","current":-7.372996,"twenty":-10.610132,"median":-8.0597,"eighty":-3.645941,"marketCap":109715986},{"date":"2025-04-04","current":-6.125431,"twenty":-10.607197,"median":-8.00338,"eighty":-3.648656,"marketCap":91151239},{"date":"2025-04-11","current":-5.81073,"twenty":-10.603154,"median":-7.947618,"eighty":-3.675163,"marketCap":86468239},{"date":"2025-04-17","current":-5.911884,"twenty":-10.594569,"median":-7.935965,"eighty":-3.675163,"marketCap":87973489},{"date":"2025-04-25","current":-6.945902,"twenty":-10.592423,"median":-7.877698,"eighty":-3.682488,"marketCap":103360487},{"date":"2025-05-02","current":-7.159449,"twenty":-10.558363,"median":-7.770143,"eighty":-3.684363,"marketCap":106538237},{"date":"2025-05-09","current":-6.799791,"twenty":-10.517537,"median":-7.71646,"eighty":-3.684448,"marketCap":101186237},{"date":"2025-05-16","current":-5.787895,"twenty":-10.501662,"median":-7.494675,"eighty":-3.685787,"marketCap":99179238},{"date":"2025-05-23","current":-5.573167,"twenty":-10.491151,"median":-7.462911,"eighty":-3.690819,"marketCap":95499738},{"date":"2025-05-30","current":-5.204226,"twenty":-10.481448,"median":-7.372996,"eighty":-3.692949,"marketCap":89177689},{"date":"2025-06-06","current":-5.631729,"twenty":-10.475105,"median":-7.356137,"eighty":-3.693585,"marketCap":96503238},{"date":"2025-06-13","current":-5.241315,"twenty":-10.467261,"median":-7.341641,"eighty":-3.701875,"marketCap":89813239},{"date":"2025-06-20","current":-5.37796,"twenty":-10.461335,"median":-7.3168,"eighty":-3.709244,"marketCap":92154738},{"date":"2025-06-27","current":-5.758614,"twenty":-10.45223,"median":-7.265955,"eighty":-3.713213,"marketCap":98677488},{"date":"2025-07-03","current":-5.817176,"twenty":-10.430063,"median":-7.253076,"eighty":-3.716195,"marketCap":99680988},{"date":"2025-07-11","current":-6.17343,"twenty":-10.378286,"median":-7.213454,"eighty":-3.720955,"marketCap":105785612},{"date":"2025-07-18","current":-5.817176,"twenty":-10.3533,"median":-7.163144,"eighty":-3.721218,"marketCap":99680988},{"date":"2025-07-25","current":-6.558964,"twenty":-10.350896,"median":-7.092013,"eighty":-3.724902,"marketCap":112391986},{"date":"2025-08-01","current":-5.807416,"twenty":-10.338323,"median":-6.99204,"eighty":-3.740857,"marketCap":99513738},{"date":"2025-08-08","current":-5.953821,"twenty":-10.32596,"median":-6.97962,"eighty":-3.74579,"marketCap":102022487},{"date":"2025-08-15","current":-4.674882,"twenty":-10.323437,"median":-6.940283,"eighty":-3.74752,"marketCap":95082085},{"date":"2025-08-22","current":-5.41908,"twenty":-10.320001,"median":-6.875506,"eighty":-3.754924,"marketCap":110218283},{"date":"2025-08-29","current":-5.517759,"twenty":-10.309706,"median":-6.854093,"eighty":-3.761854,"marketCap":112225293},{"date":"2025-09-05","current":-5.246393,"twenty":-10.301605,"median":-6.808515,"eighty":-3.76497,"marketCap":106706016},{"date":"2025-09-12","current":-5.106599,"twenty":-10.301173,"median":-6.724011,"eighty":-3.76853,"marketCap":103862753},{"date":"2025-09-19","current":-4.720109,"twenty":-10.296958,"median":-6.63442,"eighty":-3.770128,"marketCap":96001964},{"date":"2025-09-26","current":-4.366512,"twenty":-10.282185,"median":-6.51425,"eighty":-3.785695,"marketCap":88810180},{"date":"2025-10-03","current":-4.827011,"twenty":-10.275221,"median":-6.439507,"eighty":-3.802131,"marketCap":98176225},{"date":"2025-10-10","current":-5.155938,"twenty":-10.212758,"median":-6.246632,"eighty":-3.807129,"marketCap":104866257},{"date":"2025-10-17","current":-5.180608,"twenty":-10.197142,"median":-6.190468,"eighty":-3.818461,"marketCap":105368010},{"date":"2025-10-24","current":-5.739785,"twenty":-10.188138,"median":-6.125431,"eighty":-3.822481,"marketCap":116741065},{"date":"2025-10-31","current":-5.03259,"twenty":-10.181526,"median":-6.064471,"eighty":-3.822538,"marketCap":102357495},{"date":"2025-11-07","current":-4.736556,"twenty":-10.181526,"median":-6.012384,"eighty":-3.830156,"marketCap":96336466},{"date":"2025-11-14","current":-4.901019,"twenty":-10.157996,"median":-5.968462,"eighty":-3.830566,"marketCap":99681482},{"date":"2025-11-21","current":-6.788148,"twenty":-10.150294,"median":-6.012384,"eighty":-3.831749,"marketCap":125128246},{"date":"2025-11-28","current":-7.389773,"twenty":-10.150294,"median":-6.057995,"eighty":-3.836615,"marketCap":136218208},{"date":"2025-12-05","current":-6.810851,"twenty":-10.140824,"median":-6.125431,"eighty":-3.837832,"marketCap":125546736},{"date":"2025-12-12","current":-7.094636,"twenty":-10.135435,"median":-6.18807,"eighty":-3.843973,"marketCap":130777850},{"date":"2025-12-19","current":-6.016252,"twenty":-10.134497,"median":-6.219749,"eighty":-3.849238,"marketCap":110899616},{"date":"2025-12-26","current":-6.300037,"twenty":-10.125219,"median":-6.23928,"eighty":-3.850171,"marketCap":116130730},{"date":"2026-01-02","current":-6.583822,"twenty":-10.098465,"median":-6.246632,"eighty":-3.850453,"marketCap":121361844},{"date":"2026-01-09","current":-5.811926,"twenty":-10.058633,"median":-6.231928,"eighty":-3.8539,"marketCap":107133214},{"date":"2026-01-16","current":-4.574621,"twenty":-10.039554,"median":-6.190468,"eighty":-3.858435,"marketCap":84325557},{"date":"2026-01-23","current":-5.369221,"twenty":-10.03081,"median":-6.14943,"eighty":-3.858435,"marketCap":98972676},{"date":"2026-01-30","current":-5.221652,"twenty":-10.025863,"median":-6.08436,"eighty":-3.860935,"marketCap":96252497},{"date":"2026-02-06","current":-5.622234,"twenty":-10.005146,"median":-6.077653,"eighty":-3.872308,"marketCap":103636548},{"date":"2026-02-13","current":-6.029273,"twenty":-9.98508,"median":-6.08436,"eighty":-3.877804,"marketCap":111139647},{"date":"2026-02-20","current":-6.169193,"twenty":-9.97852,"median":-6.08436,"eighty":-3.877804,"marketCap":113718837},{"date":"2026-02-27","current":-6.334553,"twenty":-9.962904,"median":-6.104895,"eighty":-3.891562,"marketCap":116766971},{"date":"2026-03-06","current":-6.029273,"twenty":-9.957173,"median":-6.125431,"eighty":-3.899237,"marketCap":111139647},{"date":"2026-03-13","current":-6.041993,"twenty":-9.931673,"median":-6.125431,"eighty":-3.905437,"marketCap":111374119},{"date":"2026-03-16","current":-5.762153,"twenty":-9.931121,"median":-6.125431,"eighty":-3.905437,"marketCap":106215738}],"updateTime":1773810821175},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COYA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593418647","title":"BRIEF-Coya Therapeutics Receives Clinical Trial Application Acceptance From Health Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418647","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418647?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:20","pubTimestamp":1766496039,"startTime":"0","endTime":"0","summary":"BRIEF-Coya Therapeutics Receives Clinical Trial Application Acceptance From Health CanadaDec 23 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS RECEIVES CLINICAL TRIAL APPLICATION (CTA) ACC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA8XNHFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2593490407","title":"Coya Therapeutics Secures Health Canada Approval to Begin ALS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2593490407","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593490407?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494857,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc., a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell function in patients with neurodegenerative disorders, has received acceptance from Health Canada for its Clinical Trial Application  for COYA 302, a treatment for amyotrophic lateral sclerosis . This regulatory approval allows Coya to activate clinical trial sites in Canada, supporting and expanding patient recruitment efforts alongside ongoing U.S. sites for the ALSTARS Trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on December 23, 2025, and is solely responsible for the information contained therei","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL2HcgVr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2593490104","title":"Coya Therapeutics Inc - Alstars Trial Underway in US and Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2593490104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593490104?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA8XNHFZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2593349048","title":"Coya Therapeutics Receives Clinical Trial Application (Cta) Acceptance From Health Canada to Proceed With the Coya 302 Alstars Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2593349048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593349048?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:00","pubTimestamp":1766494801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUA8XNHFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2592901829","title":"Coya Therapeutics Receives $4.2 Million Milestone Payment for ALS Trial Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2592901829","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592901829?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:01","pubTimestamp":1765976517,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. announced that it has received a $4.2 million milestone payment under its Development and License Agreement with Dr. Reddy's Laboratories Ltd. and its affiliate, Dr. Reddy's Laboratories SA. The payment was triggered by the dosing of the first patient in the company's ALSTARS trial evaluating COYA 302 for the treatment of amyotrophic lateral sclerosis .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL77zSl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2590349830","title":"Coya Therapeutics Begins Dosing ALS Patients in ALSTARS Trial of COYA 302","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349830","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590349830?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:00","pubTimestamp":1765285249,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. has announced the commencement of patient dosing in the ALSTARS Trial, a Phase 2, randomized, multi-center, double-blind, placebo-controlled study evaluating the efficacy and safety of COYA 302 for the treatment of amyotrophic lateral sclerosis . COYA 302 is an investigational biologic combination therapy designed to enhance regulatory T cell function and suppress inflammatory myeloid activity. The trial is currently underway, and results have not yet been presented. COYA 302 is not approved by the FDA or any other regulatory agency.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on December 09, 2025, and is ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL9M4thh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2590460203","title":"Coya Therapeutics Announces Patients Have Been Dosed in the Alstars Trial of Coya 302 for the Treatment of ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2590460203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590460203?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:00","pubTimestamp":1765285203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUA8G480R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2586462473","title":"Coya Therapeutics to Join Evercore Healthcare and CTAD Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2586462473","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586462473?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:00","pubTimestamp":1764075634,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. will participate in the 8th Annual Evercore Healthcare Conference on December 2, 2025, in Miami, FL, with CEO Dr. Arun Swaminathan joining a fireside chat. On the same day, Dr. Fred Grossman, President and Chief Medical Officer, will take part in a roundtable discussion at the 18th Clinical Trials on Alzheimer's Disease  Conference in San Diego, CA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on November 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL4lWyZy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","COYA","BK4139","EVR"],"gpt_icon":0},{"id":"2582379797","title":"Coya Therapeutics reports $3.6 million collaboration revenue for Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379797","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379797?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:02","pubTimestamp":1762952578,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. reported collaboration revenues of $3.6 million for the three months ended September 30, 2025, primarily due to the recognition of $3.3 million in license revenue following FDA acceptance of its IND for a Phase 2 study. Research and development expenses were $2.9 million, up from $2.2 million in the same period last year, mainly due to increased clinical and internal research costs. General and administrative expenses rose to $2.6 million from $2.2 million. Net loss was $2.1 million, compared to a net loss of $4.0 million for the same period in 2024. As of September 30, 2025, cash and cash equivalents totaled $28.1 million. During the quarter, Coya announced FDA acceptance of its IND application for COYA 302 for ALS, received a $4.2 million milestone payment from Dr. Reddy's Laboratories, and closed a $23.0 million public offering, extending its cash runway into the second half of 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL2Fp6k3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2582814371","title":"Coya Therapeutics Inc: Anticipate Extending Our Runway Into 2H 2027 and Past Alstars Topline Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2582814371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582814371?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952407,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUA6SLJ7P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2582371898","title":"Coya Therapeutics Qtrly EPS $-0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2582371898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582371898?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952407,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUA6SLJ7P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2582027379","title":"Press Release: Coya Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2582027379","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582027379?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952400,"startTime":"0","endTime":"0","summary":"Coya Therapeutics, Inc.  , a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell  function in patients with neurodegenerative disorders, provides a corporate update and announces its financial results for the quarter ended September 30, 2025.--  Published a study in Frontiers in Immunology linking inflammation and. oxidative stress to the progression of Parkinson's disease.--  Announced FDA acceptance of Investigational New Drug  application. for COYA 302 for the treatment of Amyotrophic Lateral Sclerosis .--  Received $4.2 million from strategic partner Dr. Reddy's Laboratories. --  Launched the ALSTARS Trial, a Phase 2 clinical study to assess the. efficacy and safety of COYA 302 in ALS.--  Announced COYA 302 ALS Trial accepted by NEALS as a NEALS-affiliated. --  Completed patient enrollment in an investigator-initiated, open-label. study with low-dose IL-2 and CTLA4-Ig combination treatment in patients. set of COYA 303  and impact on s","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4007","LENZ","BK4139","AD","CNS","BK4132","COYA","BK4539"],"gpt_icon":0},{"id":"2580307867","title":"Coya Therapeutics announces results from COYA 303 in vivo animal study","url":"https://stock-news.laohu8.com/highlight/detail?id=2580307867","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580307867?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:06","pubTimestamp":1762265165,"startTime":"0","endTime":"0","summary":"Coya Therapeutics (COYA) announced results of an in vivo animal study designed to evaluate the effects of COYA 303 in a well-characterized in vivo ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-announces-results-from-coya-303-in-vivo-animal-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-announces-results-from-coya-303-in-vivo-animal-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2580731005","title":"Coya Therapeutics Reports COYA 303 Shows Potent Anti-Inflammatory Effects in Preclinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2580731005","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580731005?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:02","pubTimestamp":1762261329,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. has announced results from a preclinical in vivo animal study evaluating its investigational biologic combination, COYA 303, which consists of low-dose IL-2 and a GLP-1 receptor agonist. The study used a lipopolysaccharide  mouse model to simulate systemic and neurological inflammation representative of chronic conditions such as neurodegenerative diseases. According to the company's announcement, COYA 303 treatment significantly reduced peripheral pro-inflammatory cell expansion, enhanced regulatory T cell function, attenuated central nervous system inflammation, and promoted a shift of macrophages to an anti-inflammatory phenotype compared to controls. These findings confirm interim results previously reported by the company. Coya Therapeutics intends to publish the full dataset in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDLbGK0zD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2579604054","title":"Coya Therapeutics Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2579604054","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579604054?lang=en_us&edition=fundamental","pubTime":"2025-10-31 21:55","pubTimestamp":1761918920,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc  expected to post a loss of28cents a share - Earnings Preview Coya Therapeutics Inc COYA.OQ COYA.O is expected to  show a rise in quarterly revenue when it reports  results on No","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC1IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"1113594236","title":"Greenlight Capital's Einhorn Opts Out of AI Frenzy: \"The Math Doesn't Add Up\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1113594236","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113594236?lang=en_us&edition=fundamental","pubTime":"2025-10-30 15:20","pubTimestamp":1761808848,"startTime":"0","endTime":"0","summary":"In an era dominated by AI narratives, Greenlight Capital stands out as a contrarian voice. Founder David Einhorn, in his latest letter to investors, continues his role as a skeptic amid the tech...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECK","EIX","BK4168","LU0368265764.SGD","LU2362541513.USD","IE00BMG7P587.USD","LU0055631609.USD","IE00BD4GTV84.USD","BK4528","IE00BD4GTT62.SGD","LU0075056555.USD","BK4023","PCG","BK4588","LU2449327464.USD","LU0498741890.SGD","BK4134","IE00BMG7P926.USD","LU0498741114.HKD","AGI","BK4551","IE0031619046.USD","IE00B19Z4B17.USD","LU0630314457.HKD","LU2346227817.USD","COYA","GRBK","LU0496367417.USD","BK4017","LU0345780950.USD","BK4591","BK4585","BK4088","BK4543","LU0330918003.SGD","BK4139","LU0345781412.USD","AI","IE00B66KJ199.SGD","LU1023059493.AUD","LU2362540622.SGD","LU2362541273.HKD","IRR","BK4587","IE00BMG7P819.SGD","IE00BD4GTW91.USD","IE00BMG7P694.USD","IE00B7SZL793.SGD","LU0170899867.USD","BK4081","KD"],"gpt_icon":0},{"id":"2577563514","title":"Coya Therapeutics Shares Fall 4.5% After Co Prices Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2577563514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577563514?lang=en_us&edition=fundamental","pubTime":"2025-10-24 21:32","pubTimestamp":1761312729,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nL4N3W517W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2577636511","title":"BUZZ-U.S. STOCKS ON THE MOVE-Cipher Mining, Kura, GrafTech","url":"https://stock-news.laohu8.com/highlight/detail?id=2577636511","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577636511?lang=en_us&edition=fundamental","pubTime":"2025-10-24 21:11","pubTimestamp":1761311480,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Cipher Mining, Kura, GrafTechEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nL6N3W50JA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","TDOC","STX","EAF","CDE","INSP","IE00B19Z9505.USD","COYA","IE00BWXC8680.SGD","HUT","CL","LU2242646821.SGD","LU1206713676.USD","MOFG","LU0690374961.EUR","QLGN","LU0345770993.USD","LU1951198990.SGD","F","LU1951200564.SGD","LU1868837300.USD","PG","MHK","HCA","IE00BKVL7J92.USD","LU0477156953.USD","LU0345780521.USD","LU0006306889.USD","GD","KURA","NIC","LU0690374615.EUR","CIFR","ITW","LU1244550577.SGD","LU0345769631.USD","WU","IE00BLSP4239.USD","LU0061474960.USD","ALK","BAH","DECK","HL","XFOR","LU0683600562.USD","BK4161"],"gpt_icon":1},{"id":"2577902835","title":"BUZZ-Coya Therapeutics plunges after upsized $20 million share sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2577902835","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577902835?lang=en_us&edition=fundamental","pubTime":"2025-10-24 19:10","pubTimestamp":1761304219,"startTime":"0","endTime":"0","summary":"BUZZ-Coya Therapeutics plunges after upsized $20 million share sale** Drug developer Coya Therapeutics' COYA.O shares slide 14% to $6.01 premarket** COYA announces pricing of upsized $20 million stock offering ** Company sells 3.6 million shares at $5.50 apiece, a 21% discount to stock's last close** Lucid Capital Markets is sole book-running manager for public offering** COYA had 16.7 million outstanding shares as of June 30, according to offering prospectus** Proceeds from the offering will be used for funding its clinical development plan and other purposes** As of last close, COYA shares up 21.8% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nL6N3W50LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2577959240","title":"Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2577959240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577959240?lang=en_us&edition=fundamental","pubTime":"2025-10-24 18:30","pubTimestamp":1761301800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nTUA64WWHV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":50,"code":"91000000","status":"200"}]}}